A comparative study between transmission electron microscopy and immunofluorescence mapping in the diagnosis of epidermolysis bullosa

American Journal of Dermatopathology

Volumn 28, Issue 5, 2006, Pages 387-394

  Yiasemides, Eleni ^a,c   Walton, Judie ^a,c   Marr, Penelope ^a   Villanueva, Elmer V ^b   Murrell, Dédée F ^a,c  

^a ST GEORGE HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Electron microscopy; Epidermolysis bullosa; Immuno fluorescence mapping

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CALCULATION; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EPIDERMOLYSIS BULLOSA; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFANT; INTERMETHOD COMPARISON; MALE; NEWBORN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 33749428833     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.dad.0000211510.44865.6d     Document Type: Article

References (29)

1. Fine JD, Bauer EA, Briggaman RA, et al. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol. 1991;24:119-135.
2. Fine JD. Laboratory tests for epidermolysis bullosa. Dermatol Clin. 1994;12:123-132.
3. Bergman R. Immunohistopathologic diagnosis of epidermolysis bullosa. Am J Dermatopathol. 1999;21:185-192.
4. Fine JD. Structure and antigenicity of the skin basement membrane zone. J Cutan Pathol. 1991;18:401-409.
5. Mellerio JE. Molecular pathology of the cutaneous basement membrane zone. Clin Exp Dermatol. 1999;24:25-32.
6. Nakano A, Chao SC, Pulkkinen L, et al. Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes. Hum Genet. 2002;110:41-51.
7. Fine JD, Eady RA, Bauer EA, et al. Revised classification system for inherited epidermolysis bullosa: report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol. 2000;42: 1051-1066.
8. McGrath JA, Eady RA. The role of immunohistochemistry in the diagnosis of the non-lethal forms of junctional epidermolysis bullosa. J Dermatol Sci. 1997;14:68-75.
9. Petronius D, Bergman R, Ben Izhak O, et al. A comparative study of immunohistochemistry and electron microscopy used in the diagnosis of epidermolysis bullosa. Am J Dermatopathol. 2003;25:198-203.
10. Bolte C, Gonzalez S. Rapid diagnosis of major variants of congenital epidermolysis bullosa using a monoclonal antibody against collagen type IV. Am J Dermatopathol. 1995;17:580-583.
11. Tidman M, Eady RA. Diagnosis and diagnostic techniques. In: Management of Blistering Diseases. F W, Briggaman RA, ed. London: Chapman and Hall Ltd; 1990:167.
12. Bruckner-Tuderman L. Collagen VII and bullous disorders of the skin. Dermatology. 1994;189(Suppl 2):16-20.
13. Jaunzems AE, Woods AE, Staples A. Electron microscopy and morphometry enhances differentiation of epidermolysis bullosa subtypes. With normal values for 24 parameters in skin. Arch Dermatol Res. 1997;289:631-639.
14. Smith LT. Ultrastructural findings in epidermolysis bullosa. Arch Dermatol. 1993;129:1578-1584.
15. Jonkman MF, de Jong MC, Heeres K, et al. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest. 1995;95:1345-1352.
16. Smith FJ, Eady RA, Leigh IM, et al. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet. 1996;13:450-457.
17. McLean WH, Pulkkinen L, Smith FJ, et al. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev. 1996;10:1724-1735.
18. Hintner H, Stingl G, Schuler G, et al. Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases. J Invest Dermatol. 1981;76:113-118.
19. Verrando P, Blanchet-Bardon C, Pisani A, et al. Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. Lab Invest. 1991;64:85-92.
20. Matsui C, Nelson CF, Hernandez GT, et al. Gamma 2 chain of laminin-5 is recognized by monoclonal antibody GB3. J Invest Dermatol. 1995;105:648-652.
21. McMillan JR, McGrath JA, Pulkkinen L, et al. Immunohistochemical analysis of the skin in junctional epidermolysis bullosa using laminin 5 chain specific antibodies is of limited value in predicting the underlying gene mutation. Br J Dermatol. 1997;136:817-822.
22. Schofield OM, Fine JD, Verrando P, et al. GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: results of a multicenter study. J Am Acad Dermatol. 1990;23:1078-1083.
23. Vidal F, Aberdam D, Miquel C, et al. Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet. 1995;10:229-234.
24. Dowling J, Yu QC, Fuchs E. Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol. 1996;134:559-572.
25. Phillips RJ, Aplin JD, Lake BD. Antigenic expression of integrin alpha 6 beta 4 in junctional epidermolysis bullosa. Histopathology. 1994;24:571-576.
26. Brown TA, Gil SG, Sybert VP, et al. Defective integrin alpha 6 beta 4 expression in the skin of patients with junctional epidermolysis bullosa and pyloric atresia. J Invest Dermatol. 1996;107:384-391.
27. Morrell DS, Rubenstein DS, Briggaman RA, et al. Congenital pyloric atresia in a newborn with extensive aplasia cutis congenita and epidermolysis bullosa simplex. Br J Dermatol. 2000;143:1342-1343.
28. Bruckner-Tuderman L, Mitsuhashi Y, Schnyder UW, et al. Anchoring fibrils and type VII collagen are absent from skin in severe recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 1989;93:3-9.
29. Leigh IM, Eady RA, Heagerty AH, et al. Type VII collagen is a normal component of epidermal basement membrane, which shows altered expression in recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 1988;90:639-642.